Association of Parkinsonism and Related Disorders
Other newsitems
First Vaccine For Potential Treatment Of Parkinson's
Date: 07-06-2012
AFFiRiS AG has started the first ever Phase I clinical trial for the development of a Parkinson's vaccine (PD01A) at the Confraternität Privatklinik Josefstadt in Vienna. This is the first time a vaccine has the potential to treat the cause of Parkinson's. The study, supported generously by the US-American Michael J
AFFiRiS AG has started the first ever Phase I clinical trial for the development of a Parkinson's vaccine (PD01A) at the Confraternität Privatklinik Josefstadt in Vienna. This is the first time a vaccine has the potential to treat the cause of Parkinson's. The study, supported generously by the US-American Michael J
AFFiRiS AG has started the first ever Phase I clinical trial for the development of a Parkinson's vaccine (PD01A) at the Confraternität Privatklinik Josefstadt in Vienna. This is the first time a vaccine has the potential to treat the cause of Parkinson's. The study, supported generously by the US-American Michael J
Association of Parkinsonism and Related Disorders, Van Eeghenstraat 83, 1071 EX Amsterdam, the Netherlands
